Point72 Asia (Singapore)’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$120K Buy
15,577
+5,511
+55% +$38.6K 0.02% 407
2025
Q2
$73.6K Buy
+10,066
New +$81.2K 0.01% 527
2024
Q3
– Sell
-4,636
Closed -$64.3K – 1198
2024
Q2
$64.3K Sell
4,636
-8,048
-63% -$114K 0.01% 586
2024
Q1
$199K Buy
+12,684
New +$196K 0.05% 429

Other funds holding NEO

Point72 Asia (Singapore)'s NEO Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its NeoGenomics (NEO) stake by 55% in Q3 2025, buying an estimated $38.6K and bringing the position to 15,577 shares worth $120K. The position accounts for 0.02% of the portfolio, ranked #407.

Point72 Asia (Singapore) first reported a position in NEO in Q1 2024 and has held it in 4 quarters since. The position peaked at $199K in Q1 2024. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

  • Point72 Asia (Singapore) held 15,577 shares of NeoGenomics worth $120K as of Q3 2025.
  • Point72 Asia (Singapore) bought 5,511 NeoGenomics shares in Q3 2025, an estimated $38.6K.
  • NeoGenomics made up 0.02% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #407 holding.
  • Point72 Asia (Singapore) first reported a position in NeoGenomics in Q1 2024 and has held it in 4 quarters since.
  • Point72 Asia (Singapore)'s NeoGenomics position peaked at $199K in Q1 2024.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.